Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Max Healthcare Institute Ltd. Share Price
Day's Range
Day's Range
Low
₹1,007.40
High
₹1,024.60
Price Summary
| Previous Close | ₹1,012.50 |
|---|---|
| Day's Range | ₹1,007.40 - ₹1,024.60 |
| Open | ₹1,013.60 |
| 52 Week Range | ₹903.00 - ₹1,314.30 |
| Volume | 18,35,293 |
| Market Cap | ₹0.10 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 18,626.17 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.15 |
| Price/Earning (TTM) | 69.42 |
| TTM EPS (₹) | 14.58 |
| P/E Ratio | 99.10 |
| Book Value(₹) | 9.51 |
| PAT Margin (%) | 15.31 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 14.67 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 6974.0 | 23413.6 |
| Expenses | N/A | N/A |
| PBT | 1981.8 | 8649.6 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1382.4 | 6872.6 |
About Max Healthcare Institute Ltd.
| Founded | 2001 |
|---|---|
| Managing Director | Abhay Soi |
| NSE Symbol | MAXHEALTH |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,43,229.15 | 1,847.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,100.22 | 6,708.90 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,250.95 | 4,376.45 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,16,391.52 | 8,094.85 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,08,864.87 | 1,347.70 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,08,721.36 | 2,377.90 | 1,836.80 - 1,836.80 |
| Dr. Reddy's Laboratories Ltd. | 1,07,942.01 | 1,293.00 | 1,138.50 - 1,138.50 |
| Mankind Pharma Ltd. | 1,00,199.63 | 2,427.15 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 98,526.33 | 1,012.45 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 94,475.31 | 938.00 | 835.50 - 835.50 |
No Records Found
Latest News
Max Healthcare Institute informs about allotment of equity shares
Max Healthcare Institute has informed that Nomination & Remuneration Committee (‘NRC’) of the Company on May 1, 2026, at 6.56 pm (IST), has approved the allotment of 51,287 equity shares having face value of ₹10 each, fully paid-up, to eligible employees, consequent to the exercise of vested stock options in accordance with Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequent to the above allotment, the paid-up equity share capital of the Company stands increased from 973,19,25,020 to 973,24,37,890. In terms of regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the requisite details of equity shares allotted as above are enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Max Healthcare Institute informs about grant of options
Max Healthcare Institute has informed that Nomination and Remuneration Committee (‘NRC’) of the Company in its meeting held today March 17, 2026, has approved the grant of 50,000 stock options to an eligible employee under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 9.05 am (IST) and concluded at 9.40 am (IST). This disclosure will also be hosted on Company's website: www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Max Healthcare Institute informs about allotment of equity shares
Amrutanjan Healthcar - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 1497.68 | 1354.14 | 10.60 | 5025.53 | 4518.16 | 11.23 | 5025.53 | 4518.16 | 11.23 |
| Other Income | 47.31 | 48.19 | -1.83 | 175.74 | 176.79 | -0.59 | 175.74 | 176.79 | -0.59 |
| PBIDT | 302.74 | 225.21 | 34.43 | 932.59 | 758.79 | 22.90 | 932.59 | 758.79 | 22.90 |
| Interest | 0.46 | 0.43 | 6.98 | 1.95 | 2.19 | -10.96 | 1.95 | 2.19 | -10.96 |
| PBDT | 226.23 | 224.78 | 0.65 | 842.07 | 756.60 | 11.30 | 842.07 | 756.60 | 11.30 |
| Depreciation | 16.06 | 16.22 | -0.99 | 63.19 | 65.26 | -3.17 | 63.19 | 65.26 | -3.17 |
| PBT | 210.17 | 208.56 | 0.77 | 778.88 | 691.34 | 12.66 | 778.88 | 691.34 | 12.66 |
| TAX | 48.23 | 56.78 | -15.06 | 199.70 | 182.99 | 9.13 | 199.70 | 182.99 | 9.13 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 161.94 | 151.78 | 6.69 | 579.18 | 508.35 | 13.93 | 579.18 | 508.35 | 13.93 |
| Equity | 28.91 | 28.91 | 0.00 | 28.91 | 28.91 | 0.00 | 28.91 | 28.91 | 0.00 |
| PBIDTM(%) | 20.21 | 16.63 | 21.54 | 18.56 | 16.79 | 10.50 | 18.56 | 16.79 | 10.50 |
Pharmaids Pharmaceuticals informs about compliance report
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Max Healthcare Institute Ltd. is ₹1,012.50 as of 2026-05-08.
The market capitalisation of Max Healthcare Institute Ltd. is ₹98,526.33 as of 2026-05-08.
The 1-year return of Max Healthcare Institute Ltd. is 0.00% as of 2026-05-08.
The P/E ratio of Max Healthcare Institute Ltd. is 99.10 as of 2026-05-09.
The 52-week high and low of Max Healthcare Institute Ltd. are ₹1,314.30 and ₹903.00, respectively, as of 2026-05-08.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
